Six pharmaceutical companies are already testing their vaccines against Covid-19 in children

Until now, the antigens approved for use in the European Union are indicated in adults.

A health worker with some children during a mass screening carried out at the CEIP A Ponte educational center.

There are three vaccines against Covid-19 approved for use in the European Union. Although, at the moment, they are only indicated for adults (18 years and older), six pharmaceutical companies are already testing their antigens in children as well.

According to the specialized consultant Evaluate Pharma, Pfizer-BioNTech, Moderna, Nanogen, Sinovac, Bharat Biotech and AstraZeneca-Oxford have already launched clinical trials to determine the efficacy of their vaccines in the pediatric population.

In the case of Pfizer and BioNTech, pharmaceutical companies have already started two studies with Comarty to test it in children from 12 years. So far, they have recruited 45,528 volunteers between the two trials.

Production plant in Maburg (Germany) of the Pfizer-BioNTech vaccine

Production plant in Maburg (Germany) of the Pfizer-BioNTech vaccine

Moderna has also joined. The company has recruited 3,000 patients to study their antigen in population of between 12 and 17 years old. In the case of Nanogen, the age range starts at 12 years old, just like that of Bharat Biotech.

The last to start clinical trials in children has been AstraZeneca, which has recently received approval from the European Union for its vaccine against Covid-19. This decision has beencontroversial”, they have explained from the consultant. And it is that, the pharmacist will test its antigen in children as young as six.

“Given that young children who develop Covid-19 tend to do so asymptomatically, it could be argued that it is unethical to expose them to the risks of a clinical trial. An opinion that would change with the evidence that vaccination reduces infectiousness”, they added from Evaluate Pharma.

Although AstraZeneca’s may be a controversial decision, the consultant recalls that Sinovac is testing its vaccine on three-year-olds in China. Currently, the pharmaceutical company has recruited 552 volunteers for its clinical trial.


And it’s not just vaccines that are being studied in children. Some pharmaceutical companies are also testing their drugs against covid-19 in this population. This is the case, for example, of Regeneron, Lilly or Gilead.

The antibody of Regeneron it is the one in which more volunteers are being tested (both children and adults): 6,420. Too Lilly It has two clinical trials underway. One to study the effect of bamlanivimab in children over 12 years of age and adults, and another for the combination of this drug and etesevimab (already authorized in the United States).

Too Gilead has started two studies with its antiviral remdesivir (authorized in the European Union). The first of them to test the medicine in the population between 0 and 18 years old and another for children from 12 years old and adults.